Medicines containing the active substance anifrolumab 2026

Listed on GrantGunner. Last checked 5 Oct 2026.

About this grant

The subject of the contract is the supply of drugs for biological treatment with the active substance Anifrolumab. A detailed definition of the subject of the contract is provided in Part B.1 "Description of the subject of the contract" and B.2 "Commercial conditions for the delivery of the subject of the contract" of the tender documents.

Browse all open grants

More grants from National Institute of Rheumatic Diseases